Dr. Mayer on Tivozanib in Renal Cell Carcinoma and Breast Cancer – Video




Dr. Mayer on Tivozanib in Renal Cell Carcinoma and Breast Cancer
Erica L. Mayer, MD, MPH, assistant professor of medicine at Harvard Medical School and Dana-Farber Cancer Institute, describes studies involving tivozanib, a potent VEGF receptor tyrosine kinase inhibitor. To read more visit: http://www.onclive.comFrom:OncLiveTVViews:12 0ratingsTime:01:57More inEducation

View original post here:
Dr. Mayer on Tivozanib in Renal Cell Carcinoma and Breast Cancer - Video

Related Posts

Comments are closed.